Department of Otorhinolaryngology, Head and Neck Surgery, Gentofte University Hospital, Hellerup, Denmark.
Laryngoscope. 2010 Apr;120(4):657-62. doi: 10.1002/lary.20834.
OBJECTIVES/HYPOTHESIS: Vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) are potent mediators of tumor angiogenesis. It has been demonstrated that vestibular schwannoma VEGF expression correlates with tumor growth pattern, whereas knowledge on the expression of MMPs is lacking. This study targets the angiogenic process by investigation of tumor expression of MMP-2, MMP-9, and tissue inhibitors of metalloproteinase (TIMP)-1. A possible correlation with gender, patient age, symptom duration, tumor size, and the absolute and relative growth rate is explored.
Prospective vestibular schwannoma tissue sampling for ELISA and immunohistochemical determination of MMP-2, MMP-9 and TIMP-1.
Thirty-four patients with a sporadic, noncystic, vestibular schwannoma were selected prospectively. Repeated, preoperative magnetic resonance imaging determined the tumor growth pattern. Following translabyrinthine resection, an enzyme-linked immunosorbent assay was used for determination of the MMP-2, MMP-9, and TIMP-1 concentration in tumor sample homogenates. Immunohistochemical labeling was performed in 12 randomly selected tumors.
: All tumor homogenates expressed measurable MMP-9, MMP-2, and TIMP-1. Immunolabeling localized MMP-9 expression to the tumor cells, whereas MMP-2 and TIMP-1 was found interstitially. A significant correlation existed between the concentration MMP-9 and absolute tumor growth rate, whereas a weak correlation occurred for the relative growth rate.
Vestibular schwannomas express MMP-2, MMP-9, and TIMP-1 and the tumor concentration of MMP-9 correlates with absolute tumor growth rate, but not with age, gender, symptom duration, or preoperative tumor size. No correlations existed between any clinical parameter and MMP-2 or TIMP-1 expression. We conclude that MMP-9 appears to be involved in the growth of vestibular schwannomas.
目的/假设:血管内皮生长因子(VEGF)和基质金属蛋白酶(MMPs)是肿瘤血管生成的有力介质。已经证明,前庭神经鞘瘤 VEGF 表达与肿瘤生长模式相关,而缺乏关于 MMPs 表达的知识。本研究通过研究肿瘤 MMP-2、MMP-9 和金属蛋白酶组织抑制剂(TIMP)-1 的表达来针对血管生成过程。探讨了与性别、患者年龄、症状持续时间、肿瘤大小以及绝对和相对生长率的可能相关性。
前瞻性前庭神经鞘瘤组织取样,用于 ELISA 和 MMP-2、MMP-9 和 TIMP-1 的免疫组织化学测定。
前瞻性选择 34 例非囊性、散发性前庭神经鞘瘤患者。重复术前磁共振成像确定肿瘤生长模式。经迷路切除术后,使用酶联免疫吸附测定法测定肿瘤样本匀浆中 MMP-2、MMP-9 和 TIMP-1 的浓度。在 12 个随机选择的肿瘤中进行免疫组织化学标记。
所有肿瘤匀浆均表达可测量的 MMP-9、MMP-2 和 TIMP-1。免疫标记将 MMP-9 表达定位于肿瘤细胞,而 MMP-2 和 TIMP-1 则位于间质中。MMP-9 浓度与绝对肿瘤生长率之间存在显著相关性,而相对生长率则存在较弱相关性。
前庭神经鞘瘤表达 MMP-2、MMP-9 和 TIMP-1,MMP-9 肿瘤浓度与绝对肿瘤生长率相关,但与年龄、性别、症状持续时间或术前肿瘤大小无关。任何临床参数与 MMP-2 或 TIMP-1 表达之间均无相关性。我们的结论是,MMP-9 似乎参与了前庭神经鞘瘤的生长。